This revolutionary Centre focuses on the action and clinical use of psychedelics, with a particular focus on researching the treatment of depression.

Usona embraces the challenge of finding a better way forward. We are a non‑profit, medical research organization looking beyond the traditional treatments for depression. Our aim is to enable and support research toward the goal of an FDA registration for psilocybin as an approved medicine.

The Heffter Research Institute promotes research of the highest scientific quality with the classic
hallucinogens and related compounds (sometimes called psychedelics) in order to contribute to a greater
understanding of the mind leading to the improvement of the human condition, and to alleviate suffering.

The Beckley Foundation pioneers psychedelic research to drive evidence-based drug policy reform, founded and directed by Amanda Feilding as a UK-based think-tank and NGO.

Founded in 2016, our first major initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression.

ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world.

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.